Hypertension. 2005;45:967-973
Published online before print April 18, 2005,
doi: 10.1161/01.HYP.0000164571.77710.19
(Hypertension. 2005;45:967.)
© 2005 American Heart Association, Inc.
Angiotensin Type 2 ReceptorMediated Phosphorylation of eNOS in the Aortas of Mice With 2-Kidney, 1-Clip Hypertension
Hiromi Hiyoshi;
Katsutoshi Yayama;
Masaoki Takano;
Hiroshi Okamoto
From the Department of Pharmacology, Faculty of Pharmaceutical Sciences and High Technology Research Center, Kobe Gakuin University, Ikawadani-cho, Nishi-ku, Kobe, Japan.
Correspondence to Katsutoshi Yayama, PhD, Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Nishi-ku, Kobe 651-2180, Japan. E-mail yayama{at}pharm.kobegakuin.ac.jp
To evaluate the role of vascular angiotensin II (Ang II) type 2 (AT2) receptor in renovascular hypertension, we investigated expressions of AT2 receptor and endothelial nitric oxide synthase (eNOS) in thoracic aortas of mice with 2-kidney, 1-clip (2K1C) hypertension. The mRNA levels of AT2 receptor in aortas, but not those of AT1 and bradykinin B2 receptors, increased 14 days but not 42 days after clipping. The contractile response to Ang II (>0.1 µmol/L) was attenuated in aortic rings excised 14 days after clipping and was restored to that of rings from sham mice by antagonists of AT2 receptor (PD123319) and B2 receptor (icatibant). The aortic levels of total eNOS, phosphorylated eNOS at Ser1177 (p-eNOS), total Akt, and phosphorylated Akt at Ser473 (p-Akt) were increased in 2K1C mice on day 14, whereas only eNOS levels were increased on day 42. The aortic cGMP levels were
20-fold greater in 2K1C mice on day 14 compared with sham mice. Administration of nicardipine for 4 days before the excision of aortas 14 days after clipping not only reduced blood pressure but also decreased the aortic levels of eNOS, p-eNOS, Akt, p-Akt, and cGMP to sham levels, whereas the administration of PD123319 or icatibant to 2K1C mice decreased p-eNOS and cGMP to sham levels without affecting blood pressure and the levels of eNOS, Akt and p-Akt. These results suggest that vascular NO production is enhanced by increased eNOS phosphorylation via the activation of AT2 receptors in the course of 2K1C hypertension.
Key Words: angiotensin II bradykinin cyclic GMP nitric oxide synthase hypertension, renovascular
This article has been cited by other articles:

|
 |

|
 |
 
F. Palm, S. G. Connors, M. Mendonca, W. J. Welch, and C. S. Wilcox
Angiotensin II Type 2 Receptors and Nitric Oxide Sustain Oxygenation in the Clipped Kidney of Early Goldblatt Hypertensive Rats
Hypertension,
February 1, 2008;
51(2):
345 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox
Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H2644 - H2649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Wagenseil, R. H. Knutsen, D. Y. Li, and R. P. Mecham
Elastin-insufficient mice show normal cardiovascular remodeling in 2K1C hypertension despite higher baseline pressure and unique cardiovascular architecture
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H574 - H582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, X. Zhao, X. Li, K. M. Lerea, and S. C. Olson
Angiotensin II type 2 receptor-dependent increases in nitric oxide synthase expression in the pulmonary endothelium is mediated via a G{alpha}i3/Ras/Raf/MAPK pathway
Am J Physiol Cell Physiol,
June 1, 2007;
292(6):
C2185 - C2196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev.,
March 1, 2007;
59(1):
54 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Suzuki, K. Eguchi, H. Ohtsu, S. Higuchi, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi
Activation of Endothelial Nitric Oxide Synthase by the Angiotensin II Type 1 Receptor
Endocrinology,
December 1, 2006;
147(12):
5914 - 5920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yayama, H. Hiyoshi, D. Imazu, and H. Okamoto
Angiotensin II Stimulates Endothelial NO Synthase Phosphorylation in Thoracic Aorta of Mice With Abdominal Aortic Banding Via Type 2 Receptor
Hypertension,
November 1, 2006;
48(5):
958 - 964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Carey and J. Park
Role of Angiotensin Type 2 Receptors in Vasodilation of Resistance and Capacitance Vessels
Hypertension,
November 1, 2006;
48(5):
824 - 825.
[Full Text]
[PDF]
|
 |
|